HIFU treatment for pancreatic cancer will be broadcast on NHK WOLRD

SONIRE Therapeutics Inc. (Headquarters: Shinjuku-ku, Tokyo; President and CEO, Co-Founder: Tohru Satoh; hereinafter referred to as “SONIRE”), announces that NHK WOLRD’s “Medical Frontiers” will focus on HIFU therapy for pancreatic cancer, and the next-generation HIFU (High-Intensity Focused Ultrasound) therapy device, which has been developed by SONIRE, will be introduced in the program.

The program outline is as follows.
Title : Destroying Pancreatic Cancer With Ultrasound
Program Title : NHK World “Medical Frontiers”
Broadcast date and time :
January 8 (Mon) 23:30(JST)
January 9 (Tue) 05:30(JST)  [Rebroadcast]
January 9 (Tue) 12:30(JST)  [Rebroadcast]
January 9 (Tue) 18:30(JST)  [Rebroadcast]
January 27 (Sat) 04:30(JST) [NHK BS1]
Live streaming broadcast :
You can watch the live streaming from the official website.

On-demand Broadcasting :
After the rebroadcast ends, the program can be viewed for one year via on-demand broadcasting.

For details, please refer to the following URL.

SONIRE will continue to promote our business in order to realize the wish we put in our company name at the time of our foundation: ” Sonics(Ultrasound) Brings New Future to Cancer Patients and Families.”.

The 5th Medical Device Innovation in Kashiwa-no-ha will be held on Tuesday, October 26, 2021, and our representative, Toru Sato, will be speaking at the “Part 2: Presentations by Medical Device Venture Company”.

Tohoku University Business Innovation Center’s Venture Interview article was published

Featured in Bio Startup Directory 2021-2022 (Published by Nikkei BP and released on June 30, 2021)